Skip to content
Link copied to clipboard

Glaxo SmithKline borrows $9 billion

Glaxo SmithKline's $9 billion bond issue today is the biggest by any U.S. company since 2002, and yields are dropping as investors line up to buy the drugmaker's debt. Bloomberg story

    by Joseph N. DiStefano
    Published 

Glaxo SmithKline's $9 billion bond issue today is the biggest by any U.S. company since 2002, and yields are dropping as investors line up to buy the drugmaker's debt. Bloomberg story

» READ MORE: here

.